Short-Course Massage Therapy Enters a Randomized Test for Breast Cancer Fatigue
Cancer-related fatigue can persist long after a breast cancer diagnosis, and it often resists the usual advice to rest more or push through symptoms. Wake Forest University Health Sciences is now planning a randomized pilot trial to examine whether massage therapy can ease that burden in adults with stage 0 to III breast cancer who are actively being treated and reporting fatigue.
The study is designed as a mechanistic, waitlist-controlled trial rather than a simple satisfaction survey. Investigators will compare a brief course of massage against a non-massage control period, then measure whether symptom changes track with improvements in both patient-reported fatigue and physical performance. For a symptom that is notoriously subjective yet deeply disabling, pairing a self-reported endpoint with a walk test gives the project a more clinically grounded frame.
Why Fatigue Became the Central End Point
The protocol centers on cancer-related fatigue, a symptom that can be out of proportion to visible illness and can affect daily functioning, mood, and tolerance of ongoing treatment. In breast cancer care, fatigue is often layered on top of treatment demands, sleep disruption, emotional strain, and the physical effects of surgery, radiation, or systemic therapy. A supportive care intervention has to do more than create a temporary sense of relaxation; it has to move a reproducible symptom signal.
This trial uses the PROMIS Fatigue Short Form 7b as its primary outcome. Participants will rate fatigue on a 5-point scale with 24-hour recall, and those item responses will be summed and converted to standardized PROMIS T scores. Higher scores indicate worse fatigue, which makes the measure sensitive to symptom reduction over time. The design asks a practical clinical question: can a brief, structured manual therapy course produce measurable change in a fatigue syndrome that is often difficult to treat pharmacologically?
Randomized Waitlist Control and a Three-Week Intervention Window
The intervention arm will receive 30-minute massage sessions twice weekly for three weeks. The control arm will not receive massage during the active study phase but will complete the same non-massage assessments at matching time points, then receive massage during the non-active phase. This arrangement preserves comparison during the key observation window while still offering eventual access to the therapy.
Only 34 participants are planned, which signals a pilot study intended to generate early mechanistic insight rather than definitive efficacy claims. The study will be open-label, so neither participants nor staff are blinded. In supportive care research, that limitation is not trivial, because expectations can influence symptom reporting. Still, the protocol attempts to counterbalance that concern by incorporating an objective functional endpoint alongside the patient-reported fatigue score.
One endpoint is self-report. The other is distance walked in six minutes.
Objective Function Matters in a Symptom Trial
The secondary outcome is the six-minute walk test, a familiar clinical measure of physical performance that can reflect deconditioning, exertional tolerance, and the functional consequences of fatigue. In this setting, a longer walk distance would suggest not only that participants feel less tired but also that their body is translating that improvement into day-to-day capacity. For patients in active treatment, that distinction is clinically meaningful because fatigue often limits work, family responsibilities, and basic activities long before it appears in routine laboratory values.
By pairing subjective fatigue with an objective mobility measure, the investigators are positioning the study to ask whether massage therapy affects both perception and performance. If both move in the same direction, the intervention would look less like a transient comfort measure and more like a symptom-modifying supportive care tool.
The Massage Protocol Is Built Around Oncology-Specific Safety
The protocol does not describe generic spa-style massage. It specifies Swedish techniques adapted for oncology care, including stroking, compression, and percussion, with effleurage, petrissage, friction, tapotement, and vibration. Pressure will be guided by the Walton Pressure Scale, ranging from 1 to 3, and the therapist will not exceed WPS 3. That ceiling is intended to keep the work in a light-to-medium range generally perceived as pleasant and relaxing.
A fidelity checklist will be used to monitor delivery of the intervention, which matters in a pilot study where reproducibility is part of the scientific aim. Manual therapies often vary in pressure, tempo, and technique from one practitioner to another. Standardizing those elements gives the results a better chance of being interpretable if the trial moves toward a larger efficacy study.
The exclusion criteria also draw a safety boundary. Participants with clinically significant cardiac abnormalities that would make massage unsafe are excluded, as are people already receiving massage therapy or those enrolled in another interventional trial related to fatigue. The trial also requires participants to refrain from outside massage therapy for the duration of participation, reducing contamination across groups.
Eligibility Narrows the Sample to a Specific Clinical Niche
Adults age 18 and older with stage 0 to III breast cancer are eligible if they have self-reported fatigue documented by the treating clinician and a PHQ-9 score of 10 or less. Participants must also be available for sessions on Mondays and Wednesdays. The study does not include healthy volunteers, which keeps the focus squarely on symptomatic patients undergoing active treatment.
The depression screen is notable because fatigue and depressive symptoms can overlap. By limiting enrollment to those with PHQ-9 scores at or below 10, the protocol reduces the chance that severe mood symptoms will dominate the fatigue signal. In a symptom trial, that kind of curation is essential if the investigators want to isolate the effect of massage on fatigue rather than on broader psychological distress.
What This Pilot Can and Cannot Answer
The study is still in the planning stage, with estimated start and completion dates stretching from late 2026 to late 2028. No results are posted yet, and the sample size is small enough that broad clinical adoption would be premature even if the findings trend positive. A 34-person pilot can clarify feasibility, signal strength, and whether the fatigue trajectory appears biologically and clinically plausible after a short massage course. It cannot settle the question of who benefits most, how durable any improvement may be, or whether the same approach would hold across broader breast cancer populations.
Even so, the trial is aimed at an important gap in supportive oncology. Fatigue is common, persistent, and often undertreated, and the body-based nature of massage makes it a plausible candidate for modulating stress physiology, muscle tension, and perceived symptom burden. The real test will be whether that plausibility translates into reproducible change on a standardized fatigue scale and a six-minute walk test within the narrow three-week intervention window.